Free Trial
NYSE:USNA

USANA Health Sciences Q2 2025 Earnings Report

USANA Health Sciences logo
$30.35 -0.28 (-0.91%)
Closing price 03:59 PM Eastern
Extended Trading
$30.36 +0.01 (+0.03%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

USANA Health Sciences EPS Results

Actual EPS
N/A
Consensus EPS
$0.54
Beat/Miss
N/A
One Year Ago EPS
N/A

USANA Health Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
$225.20 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

USANA Health Sciences Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, July 23, 2025
Conference Call Time
11:00AM ET

Conference Call Resources

USANA Health Sciences Earnings Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More USANA Health Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like USANA Health Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on USANA Health Sciences and other key companies, straight to your email.

About USANA Health Sciences

USANA Health Sciences (NYSE:USNA) develops and manufactures premium nutritional products, dietary supplements, and personal care items. Founded in 1992 by researcher and entrepreneur Dr. Myron Wentz, the company has built its reputation on evidence-based formulations and rigorous scientific research. Headquartered in Salt Lake City, Utah, USANA operates through a network of independent associates who distribute its full line of health and wellness products directly to consumers.

USANA’s product portfolio spans multivitamins, targeted supplements, weight-management solutions, and skin-care collections. Leveraging proprietary manufacturing processes and a state-of-the-art production facility, the company emphasizes product purity, potency, and consistency. Flagship offerings such as its BiOmega omega-3 supplement, Procosa joint-support formula, and Celavive skin-care line illustrate USANA’s focus on tailored nutrition and personal care.

From its U.S. origins, USANA has expanded into over 20 markets across North America, the Asia-Pacific region, and Europe. The company’s direct-selling model enables rapid market entry and fosters close relationships between independent sales associates and end consumers. Key geographies include the United States, Canada, Mexico, Australia, New Zealand, South Korea, Taiwan, Hong Kong, and various Southeast Asian countries.

Listed on the New York Stock Exchange since 2001, USANA combines consumer health expertise with a global distribution network. While Dr. Wentz established its scientific foundation, today’s executive leadership team continues to drive innovation, expand market reach, and uphold the company’s commitment to advancing health through high-quality nutrition and ongoing research.

View USANA Health Sciences Profile

More Earnings Resources from MarketBeat